- Home
- STRA vs IRON Comparison
STRA vs IRON Comparison
Compare STRA & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRA
- IRON
- Stock Information
- Founded
- STRA 2017
- IRON 2017
- Country
- STRA United States
- IRON United States
- Employees
- STRA N/A
- IRON N/A
- Industry
- STRA Other Consumer Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- STRA Real Estate
- IRON Health Care
- Exchange
- STRA Nasdaq
- IRON Nasdaq
- Market Cap
- STRA 2.1B
- IRON 2.0B
- IPO Year
- STRA 1996
- IRON N/A
- Fundamental
- Price
- STRA $81.96
- IRON $60.76
- Analyst Decision
- STRA Strong Buy
- IRON Strong Buy
- Analyst Count
- STRA 3
- IRON 10
- Target Price
- STRA $104.33
- IRON $97.80
- AVG Volume (30 Days)
- STRA 130.9K
- IRON 299.1K
- Earning Date
- STRA 07-30-2025
- IRON 08-07-2025
- Dividend Yield
- STRA 2.93%
- IRON N/A
- EPS Growth
- STRA N/A
- IRON N/A
- EPS
- STRA 4.81
- IRON N/A
- Revenue
- STRA $1,242,475,000.00
- IRON N/A
- Revenue This Year
- STRA $5.58
- IRON N/A
- Revenue Next Year
- STRA $4.11
- IRON N/A
- P/E Ratio
- STRA $17.05
- IRON N/A
- Revenue Growth
- STRA 4.31
- IRON N/A
- 52 Week Low
- STRA $72.25
- IRON $30.82
- 52 Week High
- STRA $104.51
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- STRA 57.75
- IRON 56.26
- Support Level
- STRA $80.18
- IRON $59.74
- Resistance Level
- STRA $83.71
- IRON $63.51
- Average True Range (ATR)
- STRA 1.56
- IRON 2.05
- MACD
- STRA 0.34
- IRON -0.00
- Stochastic Oscillator
- STRA 69.10
- IRON 44.17
About STRA Strategic Education Inc.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.